Endoret Technology
The kit used (single use and disposable) to obtain and prepare the PRGF (Endoret) has the CE marking in accordance with the European Directive 93/42 / EEC. The preparation of PRGF (Endoret) is carried out by a specialized technician, under aseptic conditions, minimizing the risk of contamination.
PRGF (Endoret) technology accelerates the process of healing and regeneration of tissues, reducing inflammation, pain and risk of infection. It can be indicated whenever there is a need for tissue regeneration (dry eye, corneal ulcers, glaucoma surgery, persistent epithelial defects and others).
The efficacy and safety of PRGF (Endoret) technology in the treatment of various ocular pathologies has already been evaluated in several clinical studies with very favorable results.
The difference between the majority of artificial eye drops and the eye drops obtained through this technology consists of their physical and chemical characteristics, and their concentration of growth factors is very similar to natural tear favoring the regeneration of the damaged ocular tissue.


  • Autologous, because it is made from the patient’s blood, without adverse effects.
  • It has an adequate concentration of platelets that promotes a greater cellular proliferation.
  • Does not contain leukocytes, decreasing pain and inflammation.
  • Has the same pH and osmolarity as the tear, for a greater regenerative potential.
  • Has a higher anti-fibrotic potential compared to other blood products.